Question

Will bimagrumab be approved for the treatment of obesity by the FDA or EMA by 2029?

1 comment1

Total Forecasters21

Community Prediction33%

Make a Prediction

community: 32.6%

median 32.6%mean 33.3%

Authors:

casens

Opened:

Closes:

Scheduled resolution:

Health & Pandemics

Food and Drug Administration

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

43%

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

81%

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

60%

Comments

? comments

Authors:

casens

Opened:

Closes:

Scheduled resolution:

Health & Pandemics

Food and Drug Administration

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

43%

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

81%

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

60%

MetaculusM

🚀Metaculus Open-Source Rewrite is Live!

Will bimagrumab be approved for the treatment of obesity by the FDA or EMA by 2029?

Make a Prediction

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

Comments

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?